Avalide is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Irbesartan; Hydrochlorothiazide.
Product ID | 0024-5856_18162dad-7813-4074-b159-d94ce6bb5fca |
NDC | 0024-5856 |
Product Type | Human Prescription Drug |
Proprietary Name | Avalide |
Generic Name | Irbesartan And Hydrochlorothiazide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2013-01-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020758 |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | IRBESARTAN; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 300 mg/1; mg/1 |
Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020758 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-01-01 |
Marketing End Date | 2016-08-31 |
Marketing Category | NDA |
Application Number | NDA020758 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-01-01 |
Ingredient | Strength |
---|---|
IRBESARTAN | 300 mg/1 |
SPL SET ID: | 0d91895e-c869-4b33-9b83-d55c1ad6317e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0024-5855 | Avalide | irbesartan and hydrochlorothiazide |
0024-5856 | Avalide | irbesartan and hydrochlorothiazide |
0054-0254 | Irbesartan and Hydrochlorothiazide | Irbesartan and Hydrochlorothiazide |
0054-0255 | Irbesartan and Hydrochlorothiazide | Irbesartan and Hydrochlorothiazide |
0093-8232 | Irbesartan and Hydrochlorothiazide | Irbesartan and Hydrochlorothiazide |
0093-8238 | Irbesartan and Hydrochlorothiazide | Irbesartan and Hydrochlorothiazide |
0955-1045 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide |
0955-1046 | Irbesartan and Hydrochlorothiazide | irbesartan and hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AVALIDE 78260376 3068965 Dead/Cancelled |
SANOFI 2003-06-10 |
AVALIDE 75375830 2312337 Live/Registered |
SANOFI 1997-10-20 |